Cartesian Therapeutics (RNAC) Current Taxes (2021 - 2022)

Cartesian Therapeutics (RNAC) posted quarterly Current Taxes of $320000.0 for Q2 2022, little changed quarter-over-quarter from $320000.0 in Q1 2022.

Cartesian Therapeutics (RNAC) Current Taxes (2021 - 2022) Analysis & Trends

Cartesian Therapeutics (RNAC) has reported Current Taxes for 2 consecutive years, with $320000.0 the latest figure, recorded in Q2 2022.

In Q2 2022, Current Taxes changed N/A year-over-year to $320000.0; the TTM figure through Jun 2022 stood at $320000.0 (changed N/A YoY), while the FY2021 annual figure was $601000.0, changed N/A from the prior year.
Current Taxes was little changed at $320000.0 in Q2 2022 per RNAC's latest filing, from $320000.0 in the prior quarter.
Across five years, Current Taxes topped out at $15.8 million in Q3 2021 and bottomed at $320000.0 in Q1 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Current Taxes (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	-
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	49.00 Mn
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	76.32 Mn
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	59,089.99
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	-
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	-
10	Cartesian Therapeutics	265.54 Mn	265.54 Mn	-	-

Download Data